Eikonizo Therapeutics

0 followers


Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Janice Kranz
CEO & Co-Founder

Janice Kranz

Collapse
Jacob Hooker
Co-Founder
Al Schroeder
Co-Founder & Director of R&D
Florence Wagner
Director, Medicinal Chemistry
Tonya Gilbert
Director, Translational Research
Frederick 'Al' Schroeder
Co-Founder and Director of R&D
Alix Gregory
Head of Operations